318 related articles for article (PubMed ID: 28002027)
1. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
Lee JS; Gu J; Park HS; Yoo HJ; Kim HK
Clin Chem Lab Med; 2017 May; 55(6):882-889. PubMed ID: 28002027
[TBL] [Abstract][Full Text] [Related]
2. Double positivity of anti-β
Yun J; Gu J; Kim HK
J Thromb Thrombolysis; 2021 Nov; 52(4):1133-1136. PubMed ID: 33914240
[TBL] [Abstract][Full Text] [Related]
3. Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.
Kim H; Kim JE; Hwang SM; Lee HR; Han KS; Kim HK
Clin Appl Thromb Hemost; 2014 May; 20(4):442-7. PubMed ID: 23892687
[TBL] [Abstract][Full Text] [Related]
4. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
[TBL] [Abstract][Full Text] [Related]
5. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
6. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
Tonello M; Mattia E; Favaro M; Del Ross T; Calligaro A; Salvan E; Hoxha A; Fedrigo M; Ruffatti A
Thromb Res; 2019 May; 177():157-160. PubMed ID: 30903876
[TBL] [Abstract][Full Text] [Related]
7. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
[TBL] [Abstract][Full Text] [Related]
8. Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C.
Noordermeer T; Chemlal S; Jansma JJ; van der Vegte V; Schutgens REG; Limper M; de Groot PG; Meijers JCM; Urbanus RT
J Thromb Haemost; 2023 Sep; 21(9):2509-2518. PubMed ID: 37290588
[TBL] [Abstract][Full Text] [Related]
9. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
Nojima J; Kuratsune H; Suehisa E; Kitani T; Iwatani Y; Kanakura Y
Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258
[TBL] [Abstract][Full Text] [Related]
10. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic Risk of Non-Criteria Anti-Phospholipid Antibodies Measured by Line Immunoassay: Superiority of Anti-Phosphatidylserine and Anti-Phosphatidic Acid Antibodies.
Park HS; Gu JY; Jung HS; Kim HK
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868842
[TBL] [Abstract][Full Text] [Related]
12. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
Front Immunol; 2021; 12():754469. PubMed ID: 34790198
[TBL] [Abstract][Full Text] [Related]
13. Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity.
Zhang Y; Su Y; Guo H; Wang L; Li A; Wang C; Zhang J; Qiao R
Clin Biochem; 2023 Feb; 112():17-23. PubMed ID: 36535385
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
Front Immunol; 2018; 9():2971. PubMed ID: 30619328
[No Abstract] [Full Text] [Related]
15. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
16. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
Borghi MO; Beltagy A; Garrafa E; Curreli D; Cecchini G; Bodio C; Grossi C; Blengino S; Tincani A; Franceschini F; Andreoli L; Lazzaroni MG; Piantoni S; Masneri S; Crisafulli F; Brugnoni D; Muiesan ML; Salvetti M; Parati G; Torresani E; Mahler M; Heilbron F; Pregnolato F; Pengo M; Tedesco F; Pozzi N; Meroni PL
Front Immunol; 2020; 11():584241. PubMed ID: 33178218
[TBL] [Abstract][Full Text] [Related]
17. Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome.
Yin D; de Groot PG; Ninivaggi M; Devreese KMJ; de Laat B
Thromb Haemost; 2021 Sep; 121(9):1220-1227. PubMed ID: 33385181
[TBL] [Abstract][Full Text] [Related]
18. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.
Hoxha A; Mattia E; Tonello M; Grava C; Pengo V; Ruffatti A
Clin Chem Lab Med; 2017 May; 55(6):890-898. PubMed ID: 27816952
[TBL] [Abstract][Full Text] [Related]
19. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
[TBL] [Abstract][Full Text] [Related]
20. Anti-phosphatidylserine, anti-cardiolipin, anti-β2 glycoprotein I and anti-prothrombin antibodies in recurrent miscarriage at 8-12 gestational weeks.
Sater MS; Finan RR; Abu-Hijleh FM; Abu-Hijleh TM; Almawi WY
Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):170-4. PubMed ID: 22555404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
